• University of Pennsylvania (B.A., 1987, summa cum laude)
  • Yale Law School (J.D.,1990, Coker Fellow)


  • District of Columbia
  • United States Supreme Court
  • United States District Court for the District of Colorado, and the District of Columbia
  • United States Court of Appeals for the Fourth, Fifth, Sixth, Seventh, Eighth, Tenth, and District of Columbia Circuits



Eric G. Lasker litigates a wide variety of complex civil matters, with a current focus on toxic torts, environmental litigation, Alien Tort Statute litigation, and pharmaceutical products liability.  He has successfully represented his clients' interests as lead counsel in jury trials and bench proceedings and in oral argument in multiple federal courts of appeal.  In 2013, Mr. Lasker was named by Law360 as one of its five national Products Liability MVPs.

Mr. Lasker was recognized by The American Lawyer as "Litigator of the Week" and featured on the Bloomberg News program "Rainmakers" for his work in securing a victory for Firm client, DynCorp International.  In 2013, the U.S. District Court for the District of Columbia granted summary judgment to DynCorp, dismissing the sole remaining human health and medical monitoring claims brought by 3,200 Ecuadorans claiming personal injury and property damage in connection with counternarcotics aerial herbicide spraying operations in southern Colombia.  DynCorp is a contractor to the U.S. Department of State and assists with the joint United States-Colombia war-on-drugs initiatives known as “Plan Colombia.”  See Arias, et al. v. DynCorp, et al., 928 F.Supp.2d 10, 2013 WL 821168 (D.D.C. Feb. 19, 2013).  Mr. Lasker subsequently defended those victories before the U.S. Court of Appeals for the D.C. Circuit.  See Arias v. DynCorp, 752 F.3d 1011 (D.C. Cir. 2014).

Mr. Lasker has significant experience defending against all matter of legal claims involving FDA-regulated and EPA-regulated products and alleged toxins and environmental contaminants.  He has represented clients in pharmaceutical products liability claims involving antipsychotic medications, obstetrical drugs, antifungals, antiepileptics, contact and intraocular lenses, and cough/cold medicines, and in toxics/environmental matters involving herbicides, asbestos, lead paint, nonionizing radiation, and chemical solvents.  He has represented clients in matters arising both in the United States and abroad, and in matters arising under both domestic and international law.  Mr. Lasker's practice also includes matters involving sensitive national security issues, and he has represented his clients’ interests in meetings with both U.S. and foreign government officials.  He has extensive expertise in developing and implementing sophisticated medical causation and science-based defenses, and he has successfully litigated issues involving Daubert, the federal preemption defense, and natural resource damages claims.  See New Mexico v. General Electric, 467 F.3d 1223 (10th Cir. 2006).  He also assists clients in due diligence investigations as relates to environmental and toxics liabilities and through an active amicus practice on behalf of various industry organizations, including the United States Chamber of Commerce, the National Association of Manufacturers, the American Chemistry Council, the American Coatings Association, and the Washington Legal Foundation, among others.

Mr. Lasker played a prominent role in helping to establish asbestos defendants’ rights to insurance non-products coverage through a successful amicus effort that secured one of the seminal judicial opinions recognizing the existence of such coverage, litigation efforts resulting in securing several hundreds of millions of dollars in asbestos non-products insurance recoveries, and oral presentations and publications on issues involving non-products coverage.  He has also defended personal injury claims in asbestos litigation, advancing medical causation defenses as the asbestos litigation has extended to tertiary and even more remotely-situated corporate defendants.

Mr. Lasker is frequently requested to speak and publish on issues of interest to his clients.  He is the recipient of the 2012 George Yancey Memorial Award and the 2014 Burton Award for excellence in legal writing. 

Mr. Lasker currently serves on the CLE Committee of the International Association of Defense Counsel (IADC), which has responsibility over all CLE programming at IADC's midyear and annual meetings as well as oversight of CLE programming at its Corporate Counsel College and International Corporate Counsel College.  He previously served as the Chair of the IADC Toxics & Hazardous Substances Committee and on the Board of Editors of LJN's Product Liability Law & Strategy newsletter.  He is a member of the Defense Research Institute (DRI).

Mr. Lasker is recognized in 2015 by the International Who's Who Legal Life Sciences as a leader in the field of product liability.  He is named in the 2014 Washington, DC edition of Super Lawyers, and listed as a Top Rated Lawyer™ by American Lawyer Media & Martindale-Hubbell™.